startup

Tubulis

Reimagining Antibody Drug Conjugates Protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
  • Life Science & Healthcare
  • Startup Stage
  • Sale of Services
  • B2B
  • 2019
  • 1-10 Employees
  • Found
  • Planegg, DE
  • tubulis.com
  • Tubulis GmbH
  • Bayern

Profile is not claimed et

This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.

Is this your company? Claim profile

About the Team

Are you part of this team?

Management

Jonas Helma-Smets Geschäftsführer
since 2019
Dominik Schumacher Geschäftsführer
since 2019

News about Tubulis

Latest feature of Tubulis:

German Startup Awards 2025 – Die Finalisten
German Startup Awards 2025 – Die Finalisten
Medizintechnik, KI & Nachhaltigkeit: Diese Gründer, Investoren und Innovatoren gestalten die Zukunft – die Finalisten der German Startup Awards 2025 stehen fest!
Startbase
01.04.2025 »

Recent mentions of Tubulis in podcasts & videos:

Jobs at Tubulis:

Related companies

High-Tech Gründerfonds
High-Tech Gründerfonds
Investor 2005 Bonn
High-Tech Gründerfonds
High-Tech Gründerfonds (HTGF) is Germany's most active early-stage investor for young, innovative technology start-ups.
Ineratec
Startup 2016 Karlsruhe
Ineratec
With the innovative chemical reactor technology from INERATEC, gases can be converted on a decentralized scale into liquid energy carriers or valuable chemical products.
aleph alpha
aleph alpha
Startup 2019 Heidelberg
aleph alpha
Our mission is a European generalizable AI.
SciRhom
Startup 2016 Planegg
SciRhom
Developing drugs to combat life-threatening diseases.
Enpal
Startup 2017 Berlin
Enpal
Platform that digitizes the planning of a solar system and mediates between end customers and craftsmen.

Other Startups nearby

Incyton
Startup 2018 Planegg
Incyton
Automation and optimization of cell-based assays by combining precise sensor technology for key cellular parameters and tuned actuator technology.
OmicsChart (Planegg)
Startup 2022 Planegg
OmicsChart (Planegg)
Platform for neopeptide identification using sequencing data from individual patients.
Lindis Biotech
Startup 2010 Planegg
Lindis Biotech
Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Bind-X
Startup 2013 Planegg
Bind-X
Industrial applications in the field of biotechnology.
SciRhom
Startup 2016 Planegg
SciRhom
Developing drugs to combat life-threatening diseases.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen